LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.

    Kheir, Matthew / Saleem, Farah / Wang, Christy / Mann, Amardeep / Chua, Jimmy

    PloS one

    2021  Volume 16, Issue 3, Page(s) e0248358

    Abstract: ... whether admission albumin levels reliably predict outcomes in COVID-19 patients.: Methods: We retrospectively ... appear to be a predictive biomarker for outcomes in COVID-19 patients. We found that higher albumin ... reviewed 181 patients from two hospitals who had COVID-19 pneumonia confirmed by polymerase chain reaction ...

    Abstract Background: Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients.
    Methods: We retrospectively reviewed 181 patients from two hospitals who had COVID-19 pneumonia confirmed by polymerase chain reaction (PCR) testing and radiologic imaging, who were hospitalized between March and July 2020. We recorded demographics, COVID-19 testing techniques, and day of admission labs. The outcomes recorded included the following: venous thromboembolism (VTE), acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, discharge with new or higher home oxygen supplementation, readmission within 90 days, in-hospital mortality, and total adverse events. A multivariate modified Poisson regression analysis was then performed to determine significant predictors for increased adverse events in patients with COVID-19 pneumonia.
    Results: A total of 109 patients (60.2%) had hypoalbuminemia (albumin level < 3.3 g/dL). Patients with higher albumin levels on admission had a 72% decreased risk of developing venous thromboembolism (adjusted relative risk [RR]:0.28, 95% confidence interval [CI]:0.14-0.53, p<0.001) for every 1 g/dL increase of albumin. Moreover, higher albumin levels on admission were associated with a lower risk of developing ARDS (adjusted RR:0.73, 95% CI:0.55-0.98, p = 0.033), admission to the ICU (adjusted RR:0.64, 95% CI:0.45-0.93, p = 0.019), and were less likely to be readmitted within 90 days (adjusted RR:0.37, 95% CI:0.17-0.81, p = 0.012). Furthermore, higher albumin levels were associated with fewer total adverse events (adjusted RR:0.65, 95% CI:0.52-0.80, p<0.001).
    Conclusions: Admission serum albumin levels appear to be a predictive biomarker for outcomes in COVID-19 patients. We found that higher albumin levels on admission were associated with significantly fewer adverse outcomes, including less VTE events, ARDS development, ICU admissions, and readmissions within 90 days. Screening patients may lead to early identification of patients at risk for developing in-hospital complications and improve optimization and preventative efforts in this cohort.
    MeSH term(s) Aged ; Aged, 80 and over ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/pathology ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Female ; Hospital Mortality ; Humans ; Hypoalbuminemia/complications ; Hypoalbuminemia/diagnosis ; Intensive Care Units ; Male ; Middle Aged ; Prognosis ; RNA, Viral/metabolism ; Respiratory Distress Syndrome/diagnosis ; Respiratory Distress Syndrome/etiology ; Retrospective Studies ; Reverse Transcriptase Polymerase Chain Reaction ; Risk Factors ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Serum Albumin/analysis ; Venous Thromboembolism/diagnosis ; Venous Thromboembolism/etiology
    Chemical Substances RNA, Viral ; Serum Albumin
    Language English
    Publishing date 2021-03-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0248358
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.

    Matthew Kheir / Farah Saleem / Christy Wang / Amardeep Mann / Jimmy Chua

    PLoS ONE, Vol 16, Iss 3, p e

    2021  Volume 0248358

    Abstract: ... whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods We retrospectively reviewed ... 181 patients from two hospitals who had COVID-19 pneumonia confirmed by polymerase chain reaction (PCR ... a predictive biomarker for outcomes in COVID-19 patients. We ... ...

    Abstract Background Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods We retrospectively reviewed 181 patients from two hospitals who had COVID-19 pneumonia confirmed by polymerase chain reaction (PCR) testing and radiologic imaging, who were hospitalized between March and July 2020. We recorded demographics, COVID-19 testing techniques, and day of admission labs. The outcomes recorded included the following: venous thromboembolism (VTE), acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, discharge with new or higher home oxygen supplementation, readmission within 90 days, in-hospital mortality, and total adverse events. A multivariate modified Poisson regression analysis was then performed to determine significant predictors for increased adverse events in patients with COVID-19 pneumonia. Results A total of 109 patients (60.2%) had hypoalbuminemia (albumin level < 3.3 g/dL). Patients with higher albumin levels on admission had a 72% decreased risk of developing venous thromboembolism (adjusted relative risk [RR]:0.28, 95% confidence interval [CI]:0.14-0.53, p<0.001) for every 1 g/dL increase of albumin. Moreover, higher albumin levels on admission were associated with a lower risk of developing ARDS (adjusted RR:0.73, 95% CI:0.55-0.98, p = 0.033), admission to the ICU (adjusted RR:0.64, 95% CI:0.45-0.93, p = 0.019), and were less likely to be readmitted within 90 days (adjusted RR:0.37, 95% CI:0.17-0.81, p = 0.012). Furthermore, higher albumin levels were associated with fewer total adverse events (adjusted RR:0.65, 95% CI:0.52-0.80, p<0.001). Conclusions Admission serum albumin levels appear to be a predictive biomarker for outcomes in COVID-19 patients. We ...
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top